Statistics for Bridgebio Pharma (id:7524 BBIO)

Valuation metrics

Market cap

4.56B

Enterprise value

6.16B

Trailing P/E (ttm)

-5.93

Forward P/E

-7.88

PEG ratio

-7.88

Price/Sales (ttm)

20.92

Price/Book (mrq)

-4.06

Enterprise Value/Revenue

28.29

Enterprise Value/EBITDA

-12.08

Overview

Shares outstanding

188.03M

Float

128.17M

Shares short

17.20M

% Held by insiders

0.05%

% Held by institutions

0.96%

Average volume (10 days)

1.90M

Average volume (90 days)

Price summary

52-Week low

21.62

52-Week high

44.32

52-Week change

-27.20%

Beta

1.09

50-Day moving average

25.78

200-Day moving average

27.63

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-201.53%

Operating margin

-6,849.52%

Operational effectiveness

Return on assets

-48.88%

Return on equity

47.91%

Income statement

Revenue (ttm)

1.19

Revenue per share (ttm)

1.19

Quarterly revenue growth (yoy)

Gross profit (ttm)

6.86M

EBITDA

-509,903,008.00

Net income to common (ttm)

-438,860,000.00

Diluted EPS (ttm)

-2.64

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

266.32M

Total cash per share (mrq)

1.41

Total debt (mrq)

1.73B

Total Debt/Equity (mrq)

-1.60

Current ratio (mrq)

319.30%

Book value per share (mrq)

-6.51

Cash flow

Cash flow statement

-450,219,008.00

Levered free cash flow (LFCF)

-365,117,120.00